Hosted on MSN
Graves' disease is a great risk of recurrence...The Korean Society of Endocrinology announces the la...
Graves' disease is a disease in which thyroid function is excessively elevated due to an autoimmune response. Anti-thyroid ...
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...
The Healthy @Reader's Digest on MSN
The 14 Most Common Autoimmune Diseases—and Who’s Most at Risk for Each
Autoimmune diseases are on the rise in the U.S., with as many as 50 million Americans affected. Learn what causes them—and which symptoms could help pinpoint your problem.
From weight gain and iodine to pregnancy and exercise, a thyroid expert busts 15 persistent myths about diagnosis, symptoms, ...
Investing.com -- Biohaven (NYSE:BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA ...
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the ...
Clinical results showed that for six months after discontinuing Batoclimab, about 80% of patients maintained normal thyroid ...
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...
When Erin Moriarty—best known as Starlight in The Boys—appeared noticeably slimmer at a recent red carpet event, rumours swirled online. But the actress has now confirmed: it's not plastic ...
MedPage Today on MSN
Hormone Therapy Linked to Autoimmune Disease in Women
ORLANDO -- For postmenopausal women, use of hormone therapy was associated with a significantly higher incidence and risk of autoimmune diseases, a retrospective cohort study suggested.
On October 29, HanAll Biopharma announced its provisional consolidated financial results for the third quarter of this year. The company reported ...
People with thyroid eye disease receiving infusions of the insulin-like growth factor-1 receptor veligrotug report improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results